San Francisco, Calif. (PRWEB) January 08, 2013
Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced it will demonstrate Genedata Screener’s phenotypic screening capabilities at the 10th Annual High Content Analysis (HCA) Conference. Genedata Screener® for High Content Screening (HCS) covers complete screening analysis from cell-level data to final campaign results. Integrating with leading HCS instruments, Genedata Screener simultaneously supports multiple HCS image acquisition and analysis systems while eliminating data analysis bottlenecks and providing instant image access throughout the data analysis pipeline. Genedata Screener for HCS will be demonstrated at the 2013 HCA Conference (Fairmont Hotel; Booth #32) and will be featured in the HCA Technology Showcase on January 9.
Fulfilling the Promise of Phenotypic Screening
While HCS has become routine in drug discovery, the integration of HCS data and images into the data analysis workflow presents challenges. For example, maintaining different instruments and HCS data management systems and deploying separate image analysis solutions consumes time and resources. Additionally, this model often relies on manual workflows with inadequate image access and limitations in throughput or complexity, all of which results in lower productivity and potentially sub-optimal data analysis results. When HCS images are stored in isolated, instrument-specific image data management systems, there is little or no integration with a central-results data warehouse; relevant results are stored without a referenc
Copyright©2012 Vocus, Inc.
All rights reserved